BiOptic

BiOptic software lets AI agents screen drug molecules for potency, safety and deal value, automating pharma asset triage and diligence.

BiOptic runs AI agents that process molecular data, clinical results and economics to rank drug assets. The system checks patents, papers and biotech pipelines to speed up scouting and due diligence. It generates drug candidates and supports licensing and commercialization steps.